Department of Internal Medicine, University of Iowa, Iowa City, Iowa, United States of America.
PLoS One. 2012;7(9):e43836. doi: 10.1371/journal.pone.0043836. Epub 2012 Sep 4.
The broad applicability of RNA aptamers as cell-specific delivery tools for therapeutic reagents depends on the ability to identify aptamer sequences that selectively access the cytoplasm of distinct cell types. Towards this end, we have developed a novel approach that combines a cell-based selection method (cell-internalization SELEX) with high-throughput sequencing (HTS) and bioinformatics analyses to rapidly identify cell-specific, internalization-competent RNA aptamers.
METHODOLOGY/PRINCIPAL FINDINGS: We demonstrate the utility of this approach by enriching for RNA aptamers capable of selective internalization into vascular smooth muscle cells (VSMCs). Several rounds of positive (VSMCs) and negative (endothelial cells; ECs) selection were performed to enrich for aptamer sequences that preferentially internalize into VSMCs. To identify candidate RNA aptamer sequences, HTS data from each round of selection were analyzed using bioinformatics methods: (1) metrics of selection enrichment; and (2) pairwise comparisons of sequence and structural similarity, termed edit and tree distance, respectively. Correlation analyses of experimentally validated aptamers or rounds revealed that the best cell-specific, internalizing aptamers are enriched as a result of the negative selection step performed against ECs.
We describe a novel approach that combines cell-internalization SELEX with HTS and bioinformatics analysis to identify cell-specific, cell-internalizing RNA aptamers. Our data highlight the importance of performing a pre-clear step against a non-target cell in order to select for cell-specific aptamers. We expect the extended use of this approach to enable the identification of aptamers to a multitude of different cell types, thereby facilitating the broad development of targeted cell therapies.
RNA 适体作为治疗试剂的细胞特异性递药工具具有广泛的适用性,这取决于能否鉴定出选择性进入不同细胞类型细胞质的适体序列。为此,我们开发了一种新方法,该方法结合了基于细胞的选择方法(细胞内化 SELEX)与高通量测序(HTS)和生物信息学分析,以快速鉴定细胞特异性、内化能力强的 RNA 适体。
方法/主要发现:我们通过富集能够选择性内化入血管平滑肌细胞(VSMCs)的 RNA 适体来证明该方法的实用性。进行了几轮正选(VSMCs)和负选(内皮细胞;ECs)以富集优先内化入 VSMCs 的适体序列。为了鉴定候选 RNA 适体序列,我们使用生物信息学方法分析了每轮选择的 HTS 数据:(1)选择富集的度量标准;(2)序列和结构相似性的成对比较,分别称为编辑距离和树距离。对实验验证的适体或轮次的相关分析表明,与 ECs 进行负选富集的是最佳的细胞特异性、内化适体。
我们描述了一种新方法,该方法结合了细胞内化 SELEX 与 HTS 和生物信息学分析,以鉴定细胞特异性、细胞内化的 RNA 适体。我们的数据强调了在选择细胞特异性适体之前进行预清除步骤的重要性。我们期望这种方法的广泛应用能够鉴定出多种不同的细胞类型的适体,从而促进靶向细胞治疗的广泛发展。